The role of macrophages in chronic suppurative otitis media associated sensory hearing loss
巨噬细胞在慢性化脓性中耳炎相关感觉性听力损失中的作用
基本信息
- 批准号:10754782
- 负责人:
- 金额:$ 9.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary / Abstract
We request NIH support to investigate how sensory hearing loss (SHL) is caused by chronic suppurative otitis
media (CSOM) or severe chronic middle ear infections. CSOM, a neglected tropical disease that afflicts 330
million people worldwide, is the most common cause of permanent hearing loss among children in the
developing world. It is characterized by a chronically discharging infected middle ear, and there is currently no
effective medical therapy or cure. The bacterium, Pseudomonas aeruginosa (PA), is the leading culprit. PA
colonizes the middle ear via a hole in the tympanic membrane and establishes itself into a biofilm community,
complicating attempts to treat and fully eradicate infection. Over the course of the disease, the infection waxes
and wanes as the population of bacteria within the biofilm responds, in part, to immune attack or topical
antibiotics. This waxing and waning of bacterial infection leads to permanent sensory hearing loss via an
unknown mechanism. Our lab has recently created and validated a novel PA CSOM animal model that mimics
the human condition. Specifically, we create the infection by inoculating PA in the right state (phenotype) and
dose, which results in an infection that persists beyond six months, waxes and wanes upon topical
fluoroquinolone therapy, and leads to hair cell death, over time, like in the human disease. Previous
investigations by others relied on acute infection models based on non-PA bacteria. In contrast, our unique
model of PA CSOM now allows us to observe development of the infection in the inner ear and identify agents
and/or processes that may be causing the resulting sensory hearing loss. Our studies would help determine
whether permanent hearing loss is preventable in CSOM and, if so, guide strategies for therapeutic intervention.
Our Aims encompass: (1) determining the timing and nature of structural changes occurring within the cochlea
and assessing the macrophage distribution as these changes occur, (2) investigating potential direct hair cell
(HC) toxins and macrophage inducers through CSOM perilymph sampling, and (3) evaluating the contributions
of resident and migrating macrophages towards hair cell loss in CSOM by combining our CSOM mouse model
with the CD68-GFP transgenic reporter mouse and, separately, with a triple knockout mouse strain with
macrophages unable to produce reactive oxygen species (ROS) while also evaluating whether NLRP3
inflammasome function is necessary for HC loss in the cochlea.
Altogether these aims are a completely new approach to sensory hearing loss caused by CSOM. If successful,
these studies will support future investigations into the mechanisms in the pathophysiology of CSOM and lead
to novel treatments for PA and potential strategies to prevent sensory hearing loss in CSOM.
项目摘要 /摘要
我们要求NIH支持,以调查感觉听力损失(SHL)是如何由慢性化脓性中耳炎引起的
培养基(CSOM)或严重的慢性中耳感染。 CSOM,一种受忽视的热带疾病330
全世界有百万人民,是儿童永久性听力损失的最常见原因
发展中国家。它的特征是长期释放的中耳感染,目前没有
有效的医疗疗法或治愈。细菌铜绿假单胞菌(PA)是领先的罪魁祸首。 PA
通过鼓膜膜中的一个孔殖民中耳,并将自己建立成生物膜群落,
使治疗和完全消除感染的尝试复杂化。在疾病过程中,感染蜡
随着生物膜内细菌的种群的减弱,部分反应了免疫攻击或局部
抗生素。细菌感染的这种上蜡和减弱导致通过
未知机制。我们的实验室最近创建并验证了一种新颖的PA CSOM动物模型
人类状况。具体而言,我们通过以正确的状态接种PA(表型)和
剂量会导致感染持续超过六个月,蜡和局部衰竭
像人类疾病一样,氟喹诺酮治疗,并导致毛细胞死亡。以前的
其他人的研究依赖于基于非PA细菌的急性感染模型。相反,我们的独特
现在,PA CSOM的模型使我们能够观察内耳中感染的发展并识别药物
和/或可能导致感觉听力损失的过程。我们的研究将有助于确定
CSOM是否可以预防永久性听力损失,如果是的,则指导治疗干预的策略。
我们的目标包括:(1)确定耳蜗内发生的结构变化的时间和性质
并随着这些变化的发生评估巨噬细胞分布,(2)研究潜在的直接毛细胞
(HC)毒素和巨噬细胞通过CSOM PerilyMph采样,(3)评估贡献
通过组合我们的CSOM鼠标模型,居民和将巨噬细胞迁移到CSOM中的毛细胞损失
使用CD68-GFP转基因报告基因小鼠,并分别使用三重基因敲除小鼠应变
巨噬细胞无法产生活性氧(ROS),同时还评估NLRP3是否是否
炎性体功能对于耳蜗中的HC损失是必需的。
这些目标总的来说是CSOM引起的感觉听力损失的全新方法。如果成功,
这些研究将支持对CSOM病理生理机制的未来研究,并领导
对PA的新治疗方法和潜在的策略,以防止CSOM的感觉听力损失。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Influence of CX3CR1 Deletion on Cochlear Hair Cell Survival and Macrophage Expression in Chronic Suppurative Otitis Media.
CX3CR1 缺失对慢性化脓性中耳炎耳蜗毛细胞存活和巨噬细胞表达的影响。
- DOI:10.1097/mao.0000000000003884
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Schiel,Viktoria;Xia,Anping;SantaMaria,PeterL
- 通讯作者:SantaMaria,PeterL
Bacterial outer membrane vesicles bound to bacteriophages modulate neutrophil responses to bacterial infection.
- DOI:10.3389/fcimb.2023.1250339
- 发表时间:2023
- 期刊:
- 影响因子:5.7
- 作者:
- 通讯作者:
Rapid assessment of changes in phage bioactivity using dynamic light scattering.
使用动态光散射快速评估噬菌体生物活性的变化。
- DOI:10.1101/2023.07.02.547396
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Dharmaraj,Tejas;Kratochvil,MichaelJ;Pourtois,JulieD;Chen,Qingquan;Hajfathalian,Maryam;Hargil,Aviv;Lin,Yung-Hao;Evans,Zoe;Oromí-Bosch,Agnès;Berry,JoelD;McBride,Robert;Haddock,NaomiL;Holman,DerekR;vanBelleghem,JonasD;Chang
- 通讯作者:Chang
共 3 条
- 1
Peter Luke Santa Maria其他文献
Minimally invasive <em>trans</em>-tympanic eustachian tube occlusion animal model
- DOI:10.1016/j.ijporl.2022.11107010.1016/j.ijporl.2022.111070
- 发表时间:2022-05-012022-05-01
- 期刊:
- 影响因子:
- 作者:Ali Kouhi;Anping Xia;Kelly Khomtchouk;Peter Luke Santa MariaAli Kouhi;Anping Xia;Kelly Khomtchouk;Peter Luke Santa Maria
- 通讯作者:Peter Luke Santa MariaPeter Luke Santa Maria
共 1 条
- 1
Peter Luke Santa M...的其他基金
The role of macrophages in chronic suppurative otitis media associated sensory hearing loss
巨噬细胞在慢性化脓性中耳炎相关感觉性听力损失中的作用
- 批准号:1054401610544016
- 财政年份:2022
- 资助金额:$ 9.12万$ 9.12万
- 项目类别:
The role of macrophages in chronic suppurative otitis media associated sensory hearing loss
巨噬细胞在慢性化脓性中耳炎相关感觉性听力损失中的作用
- 批准号:1034213210342132
- 财政年份:2022
- 资助金额:$ 9.12万$ 9.12万
- 项目类别:
Development of Nanoparticle Antibiotic Adjuvant for the Treatment of Chronic Suppurative Otitis Media
纳米颗粒抗生素佐剂治疗慢性化脓性中耳炎的开发
- 批准号:1020379610203796
- 财政年份:2020
- 资助金额:$ 9.12万$ 9.12万
- 项目类别:
Development of Nanoparticle Antibiotic Adjuvant for the Treatment of Chronic Suppurative Otitis Media
纳米颗粒抗生素佐剂治疗慢性化脓性中耳炎的开发
- 批准号:1004310110043101
- 财政年份:2020
- 资助金额:$ 9.12万$ 9.12万
- 项目类别:
相似国自然基金
基于口腔灌注种植体周围炎动物模型探索多细菌感染后的宿主免疫反应机制
- 批准号:82201049
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于口腔灌注种植体周围炎动物模型探索多细菌感染后的宿主免疫反应机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腰椎终板Modic改变动物模型的建立及其评估
- 批准号:81672208
- 批准年份:2016
- 资助金额:52.0 万元
- 项目类别:面上项目
利用基因重组技术构建MRSA流行株假体关节感染模型的实验研究
- 批准号:81472108
- 批准年份:2014
- 资助金额:72.0 万元
- 项目类别:面上项目
树鼩败血症模型的创制
- 批准号:81302539
- 批准年份:2013
- 资助金额:30.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
噻唑啉-吡啶酮化合物作为结核病新药
- 批准号:1069882910698829
- 财政年份:2023
- 资助金额:$ 9.12万$ 9.12万
- 项目类别:
Impact of inflammatory lipids on Yersinia pestis infection
炎性脂质对鼠疫耶尔森菌感染的影响
- 批准号:1072264810722648
- 财政年份:2023
- 资助金额:$ 9.12万$ 9.12万
- 项目类别:
Brewing anti-toxin drugs using probiotic yeast
利用益生菌酵母酿造抗毒素药物
- 批准号:1068767010687670
- 财政年份:2023
- 资助金额:$ 9.12万$ 9.12万
- 项目类别:
Molecular regulation of immunoproteasome assembly in inflammatory diseases
炎症性疾病中免疫蛋白酶体组装的分子调控
- 批准号:1063742210637422
- 财政年份:2023
- 资助金额:$ 9.12万$ 9.12万
- 项目类别: